Congenica

Congenica is a digital health company that focuses on software and AI-powered solutions for analyzing and interpreting genomic data. Founded in 2014 as a spin-out from the Wellcome Trust Sanger Institute, Congenica aims to enhance precision medicine for inherited diseases, cancer, and other applications. The company was established by a team of leading geneticists and bioinformaticians, including notable figures from significant genomic projects. The core offering of Congenica is its proprietary platform, Sapientia™, which automates genomic data analysis and interpretation. This platform supports a range of applications, from screening whole genome sequences to identifying mutations linked to rare genetic disorders. It integrates DNA data with clinical phenotyping to facilitate faster diagnoses and therapy guidance. Congenica has established partnerships with major healthcare entities, including the NHS Genomic Medicine Service and the 100,000 Genomes Project, and has expanded its reach to over 20 countries, including the US and China.